Time-dependent alterations in serum NO concentration after oral administration of l-arginine, l-NAME, and allopurinol in intestinal ischemia/reperfusion by Yanni, Amalia E et al.
© 2008 Yanni et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article 
which permits unrestricted noncommercial use, provided the original work is properly cited.
Vascular Health and Risk Management 2008:4(2) 437–441 437
ORIGINAL RESEARCH
Time-dependent alterations in serum NO 
concentration after oral administration of L-
arginine, L-NAME, and allopurinol in intestinal 
ischemia/reperfusion
Amalia E Yanni1
Eleutherios Margaritis2
Nikolaos Liarakos2
Alkisti Pantopoulou2
Maria Poulakou2
Maria Kostakis2
Despoina Perrea2
Alkis Kostakis3
1Department of Science of 
Dietetics and Nutrition, Harokopio 
University of Athens, Athens, Greece, 
2Laboratory of Experimental Surgery 
and Surgical Research, School of 
Medicine, National and Kapodistrian 
University of Athens, Athens, Greece, 
32nd Department of Propedeutic 
Surgery, School of Medicine, National 
and Kapodistrian University of Athens, 
Athens, Greece
Correspondence: Amalia E Yanni
Department of Science of Dietetics 
and Nutrition, Harokopio University, El. 
Venizelou 70, 176 71, Athens, Greece
Tel +302109549174
Fax +302109549141
Email ayanni@hua.gr
Objective: To study the effect of oral administration of a nitric oxide (NO) donor L-arginine 
(L-Arg), a NO synthase inhibitor NG-nitro-L-arginine methyl ester (L-NAME) and an inhibitor 
of xanthine oxidase, allopurinol (Allo), on serum NO concentration and catalase activity after 
intestinal ischemia/reperfusion (I/R) in rats.
Methods: Male Wistar rats received per os L-Arg (800 mg/kg) or L-NAME (50 mg/kg) or Allo 
(100 mg/kg) 24 hrs, 12 hrs and 1 hr before underwent 1 hr occlusion of superior mesenteric 
artery followed by 1 hr of reperfusion (L-Arg(IR1), L-NAME(IR1) and Allo(IR1) respectively) 
or 1 hr occlusion followed by 8 hrs of reperfusion (L-Arg(IR8), L-NAME(IR8) and Allo(IR8) 
respectively). There was one group underwent 1 hr occlusion (I), a group underwent 1 hr occlu-
sion followed by 1 hr reperfusion (IR1), a group subjected to 1 hr occlusion followed by 8 hrs 
of reperfusion (IR8) and a last group that served as control (C). Serum NO concentration and 
catalase activity were measured.
Results: After 1 hr of reperfusion serum NO concentration was elevated in IR1 and L-Arg(IR1) 
groups compared with group C but not in L-NAME(IR1) and Allo(IR1) group. Catalase activity 
was enhanced in L-NAME(IR1) group. Interestingly, serum NO concentration was increased after 
8 hrs of reperfusion in all groups (IR8, L-Arg(IR8), L-NAME(IR8) and Allo(IR8)) compared 
with control while catalase activity did not show signiﬁ  cant difference in any group.
Conclusions: The results of the present study show that NO concentration is elevated in 
serum after intestinal I/R and the elevation sustained after administration of L-Arg but not after 
administration of L-NAME or Allo after 1 hr reperfusion. However, after 8 hrs of reperfusion NO 
concentration was increased in all groups studied, focusing attention on its possible important 
role in a complicated situation such as intestinal I/R that involves intestine and other organs. 
Serum catalase activity does not seem to be affected by per os supplementation of L-Arg or 
Allo in intestinal I/R.
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Introduction
Ischemia/reperfusion (I/R) of mesenteric vessels is involved in several clinical-surgical 
conditions and often becomes life threaten (Schoenberg and Beger 1993; Massberg 
and Messmer 1998; Oldenburg et al 2004) Discontinuation of nutritive blood ﬂ  ow to 
the intestine leads to tissue damage, which can be irreversible. During ischemia, but 
especially during reperfusion, inﬂ  ammatory factors are generated, cytotoxic substances 
are released, enzymes and immune cells are implicated in tissue injury. Mechanisms 
underlying the pathophysiology of I/R are not clearly understood (Takada et al 1998; 
Cerquiera et al 2005).Vascular Health and Risk Management 2008:4(2) 438
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A large number of studies have been focused on nitric 
oxide (NO) (Moncada et al 1991; Kurose et al 1994; Takada 
et al 1998; Cerquiera et al 2005), a highly reactive substance 
with a highly conﬂ  icting role. NO exerts beneﬁ  cial effects as 
a strong vasodilator and protector of vascular integrity. There 
are studies showing that NO reduces mucosal injury after I/R 
(Kubes and Granger 1992) and decreases lung injury caused 
by intestinal ischemia (Terada et al 1996). On the other hand 
NO reacts with superoxide anion leading to the formation of 
peroxinitrite (ONOO-) an oxidative agent capable to cause 
tissue damage (Takada et al 1998; Cuzzocrea et al 1998).
The aim of the present study is to investigate the effect 
of oral administration of substances that are related to NO 
metabolism in serum NO concentration in rats underwent 
superior mesenteric artery ischemia followed by 1 hr or 8 hrs 
of reperfusion. A NO donor L-arginine (L-Arg), a NO syn-
thase inhibitor NG-nitro-L-arginine methyl ester (L-NAME) 
and an antioxidant allopurinol (Allo) were studied.
Although there is no direct link between NO metabolism 
and catalase activity, assessment of an antioxidant enzyme in 
a process such as ischemia/reperfusion where oxidative stress 
plays major role in tissue injury, in combination with a possible 
oxidative role of NO supported by bibliography, is thought to 
be important (Kacmaz et al 1999; Song et al 2007). Hence, the 
effect of the above mentioned substances in the antioxidant 
enzyme catalase under I/R was also given attention.
Methods
Animals
Male Wistar rats (2 months old) weighting 250–350 g 
participated in the study. Animals were fed a standard rat 
chow and had free access to tap water. They were housed 
in groups of two, in cages with wood shaving as bedding 
in an air conditioned room with 20 ± 2 °C temperature, 
55 ± 10% humidity and 12 hr light-dark cycle (light on at 
5:30 a.m.). Rats were left to adapt in the laboratory envi-
ronment for 1 week. These animals had not participated in 
any other experimental procedure before and a veterinarian 
was observing their health and general condition during the 
adaptation period. 24 hrs prior to experimentation animals 
were fasted but free access to water was allowed.
All protocols were approved by the Institute’s Ethics 
Committee and conducted in compliance with the European 
Convention on Animal Care.
Experimental protocol
Rats were divided into ten groups of 8 animals each. In group 
C (control) animals did not receive any substance. In group 
I animals underwent 1 hr occlusion of superior mesenteric 
artery while in groups IR1 and IR8 1 hr occlusion was fol-
lowed by 1 hr and 8 hrs reperfusion respectively. The rest 
groups received per os L-Arg (800 mg/kg) or L-NAME 
(50 mg/kg) or Allo (100 mg/kg) 24 hrs, 12 hrs and 1 hr in 
equal doses before underwent 1 hr occlusion of superior 
mesenteric artery followed by 1 hr reperfusion (L-Arg(IR1), 
L-NAME(IR1) and Allo(IR1) respectively) or 1 hr occlusion 
of superior mesenteric artery followed by 8 hrs reperfusion 
(L-Arg(IR8), L-NAME(IR8) and Allo(IR8) respectively).
Anesthesia was induced by intramuscular injection of 
xylazine (10 mg/kg) and ketamine (100 mg/kg) and ani-
mals were placed on heating pads for maintenance of body 
temperature at 37 °C. Supplementary half of the initial dose 
was given intraperitonealy 40 min after the beginning of the 
surgical operation. Animals in group C subjected to a midline 
abdominal incision and sacriﬁ  ced after blood collection from 
inferior vena cava. In rest groups, superior mesenteric artery 
was isolated and occluded with an atraumatic microvascular 
clamp for 1 hr to obtain ischemia. After this period of time 
clamp was removed and the reperfusion period started with 
return of mesenteric blood ﬂ  ow in all groups.
Analyses of NO and catalase
Total NO concentration was measured in serum with a 
commercial enzyme-linked immunosorbent assay (ELISA) 
kit (Assay Designs, Inc, Ann Arbor, MI). The method is 
based on Griess reaction and determines the two stable 
breakdown products of NO, nitrite, and nitrate. Brieﬂ  y, 
nitrate is enzymatically converted to nitrite by the enzyme 
nitrate reductase. Nitrite is measured as an azo dye product 
of Griess reaction that absorbs light at 540 nm.
Catalase activity was also measured in serum by an 
ELISA kit (Cayman Chemical, Ann Arbor, MI). The method 
is based on the production of a purple product via the reaction 
of formaldehyde with a chromogen. Formaldehyde is formed 
by catalase action on methanol in the presence of H2O2.
Statistical analysis
Statistical analysis was performed using SPSS 10.0 statistical 
software. Data are presented as mean ± standard error of 
mean (SEM). Statistical signiﬁ  cance was determined by 
Student’s t-test for independent samples. p value less than 
0.05 (p  0.05) was considered statistically signiﬁ  cant.
Results
Serum NO concentration was elevated signiﬁ  cantly after 1 hr 
reperfusion and after 1 hr reperfusion with prior administration Vascular Health and Risk Management 2008:4(2) 439
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of L-Arg (Figure 1). Ischemia did not increase NO concentration, 
since in group I, NO levels did not have any statistical difference 
from group C (p  0.05). However, 1 hr reperfusion followed 
resulted in signiﬁ  cant increase (85.5 ± 15.06 in IR1 group vs 
33.91 ± 5.71 µmol/L in group C, mean ± SEM, p  0.05). 
L-Arg maintained serum NO elevation since the animals that 
received L-Arg prior to I/R had higher levels of NO when 
compared with control (94.77 ± 15.80 in L-Arg(IR1) group vs 
33.91 ± 5.71 µmol/L in group C, p  0.05).
NO levels in L-NAME(IR1) group did not have any sig-
niﬁ  cant difference from control animals. Probably L-NAME 
prevented NO elevation, which is caused by reperfusion 
during the ﬁ  rst hr (p  0.05).
In the group of animals received allopourinol, Allo(IR1), 
serum NO concentration was 34.60 ± 7.35 µmol/L after 1 hr 
ischemia followed by 1 hr reperfusion and did not have any 
statistical difference from control group (p  0.05).
Serum NO levels were significantly elevated in all 
treatment groups compared to control when ischemia was 
followed by 8 hrs of reperfusion. Hence, NO values were 
94.85 ± 15.10 in L-Arg(IR8) group, 104.70 ± 17.10 in L-
NAME(IR8) group and 94.38 ± 18.61 µmol/L in Allo(IR8) 
group (p  0.05 vs control).
L-Arg and Allo did not seem to affect catalase activ-
ity in serum as it is presented in Table 1. However, its 
activity was signiﬁ  cantly higher in L-NAME(IR1) group 
(55.98 ± 5.95 vs 33.16 ± 2.72 nmol/min/mL in group C, 
p  0.05; Table 1). After 8 hrs of reperfusion this effect 
did not exist.
Discussion
The present study was designed to set light on the mechanisms 
underlying the metabolic processes involved in intestinal I/R 
related to release of substances into circulation, which may affect 
the intestine or other organs. Due to the fact that a large number 
of studies have been focused on the role of NO and antioxidant 
enzymes in intestinal I/R, the effect of oral administration of 
L-Arg, L-NAME, and allopurinol on serum NO concentration 
and catalase activity in intestinal I/R was studied.
L-Arg is the precursor of NO synthesis via the reaction that 
converts L-Arg to L-citrulline and catalyzed by NO synthase 
(NOS). NOS exists in various isoforms. Studies have shown 
that among them, inducible form (iNOS) is thought to be the 
one leads to the formation of excessive NO that causes tissue 
injury in intestinal I/R (Gross and Wolin 1995; Naito et al 
2002). However, L-Arg administration has been shown to 
ameliorate serum and pulmonary cytokine response after gut I/R 
(Fu et al 2005) and to exert protective effects on reperfusion 
after pancreaticoduodenal transplantation in rats (Yuan et al 
2004). L-NAME is a potent competitive NOS inhibitor that 
restricts NO formation and allopurinol is a competitive inhibi-
tor of xanthine oxidase, an enzyme that is strongly related 
to I/R injury. Xanthine oxidase is another form of xanthine 
deydrogenase which normally catalyses the metabolism of 
Figure 1 Time-dependent alterations in serum NO concentration after oral administration of L-Arg, L-NAME and Allo in 1 hr ischemia followed by 1 hr (L-Arg(IR1), 
L-NAME(IR1) and Allo(IR1)) or 8 hrs (L-Arg(IR8), L-NAME(IR8) and Allo(IR8)) of reperfusion. After 8 hrs of reperfusion all treated groups have elevated serum NO concen-
tration. *p  0.05 compared to group C.Vascular Health and Risk Management 2008:4(2) 440
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xanthine to uric acid with NAD+ as electron acceptor. During 
ischemia xanthine dehydrogenase is converted to xanthine 
oxidase which catalyses the reaction of xanthine to hypoxan-
thine that is subsequently accumulated in intestinal tissue due 
to ischemia. After reoxygenation hypoxanthine is degradated 
to uric acid using molecular oxygen as electron acceptor and 
leads to the formation of free radicals (Schoenberg and Beger 
1993). Allopurinol decreases the rate of formation of free 
radicals and prevents tissue injury after reperfusion (Parks and 
Granger 1983; Schoenberg and Beger 1993). Additionally, 
xanthine oxidase induces retention of neutrophils in the lung 
after intestinal I/R (Terada et al 1996).
The results of the present study revealed that serum NO 
concentration was raised after I/R. This ﬁ  nding has also 
been demonstrated by other researchers (Xia et al 2001). It is 
important to note that NO concentration was not affected by 
ischemia per se but only after reperfusion in which the major 
alterations in tissue metabolism are attributed. This rise in 
serum NO may reﬂ  ect a protective mechanism for secondarily 
injured organs. It has been suggested that even 30 minutes 
of intestinal I/R can initiate pulmonary inﬂ  ammation and 
that endogenous NO limits lung injury after intestinal I/R in 
rats (Terada et al 1996). Accordingly, L-Arg administration 
maintained elevated serum NO concentration after I/R and 
may contribute to endogenous NO protection. However, 
L-Arg did not result in an additional rise of NO showing that 
this enhancement of concentration maybe closed under limits. 
Interestingly, NO concentration after L-Arg administration 
remained almost constant during 8 hrs of reperfusion.
L-NAME and Allo did not have any effect on serum NO 
levels compared with control after 1 hr reperfusion. L-NAME 
as a competitive inhibitor of NOS probably restricted NO 
production that observed in I/R. It is important to note that L-
NAME administration resulted in high mortality of the animals 
during reperfusion. In contrary, animals received L-Arg were in 
a very good general condition post-operatively and this observa-
tion enhances the possibility of a beneﬁ  cial role of NO.
Allopurinol is a substance known for protection from 
tissue damage and its existence may prevented serum NO 
increment (or made it not necessary). This hypothesis is 
supported by the elevation of serum NO concentration after 
8 hrs of reperfusion when these substances would have been 
catabolized and NO production follows that observed in 
groups of IR and L-Arg. Additionally, animals post-operative 
condition was very good after Allo administration. These 
time-dependent alterations in NO concentration may reﬂ  ect a 
trend of the body to produce this substance via an endogenous 
protective mechanism which prevents inﬂ  ammation in other 
implicated to intestinal I/R, organs.
On the other hand, L-NAME gave rise to catalase activity 
in serum after 1 hr reperfusion that did not seem to be affected 
by ischemia, I/R and L-Arg or Allo administration. This ﬁ  nd-
ing is difﬁ  cult to be explained. Since the antioxidant activity 
is higher than control group our thought is led to the existence 
of an equilibrium between NO generated free radicals and 
antioxidants in normal conditions which favors antioxidants 
when L-NAME is administered. Oral administration of L-
NAME has been shown to increase catalase activity also in 
other situations (Mara et al 2007). More studies are needed 
in order to support the above-mentioned hypothesis.
Since reperfusion causes large metabolic alterations and 
NO concentration increased after I/R it would be wise to 
consider the effect of this release of NO in the circulation in 
other organs where it could be beneﬁ  cial. On the other hand 
the increase of catalase activity by L-NAME reﬂ  ects the 
complexity of NO metabolism and its different role regarding 
different tissues.
More studies are needed for the elucidation of the mecha-
nisms underlying NO metabolic responses after intestinal I/R.
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